Methods for the Assessment of Liver Function and Liver Regeneration

  • N. Tygstrup


Fulminant hepatic failure is fatal if liver function is reduced to a level incompatible with survival. This truism needs some qualification. A fatal outcome may also be due to lack of adequate treatment of treatable complications, such as gastrointestinal hemorrhage, or to complications due] to interventions, such as septicemia from intravenous lines. This makes monitoring of liver function essential. Furthermore, monitoring of the factors determining liver function, viz., the rate of regeneration and degeneration of hepatocytes, is assumed to be of significance for assessment of the prognosis.


Liver Regeneration Partial Hepatectomy Fulminant Hepatic Failure Allyl Alcohol Transform Growth Factor Alpha 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Asakawa K, Hizuka N, Takano K, Horikawa R, Sukegawa I, Toyoda C, Shizume K (1989) Human growth hormone stimulates liver regeneration in rats. J Endocrinol Invest 12: 343–347PubMedGoogle Scholar
  2. 2.
    Bernuau J, Goudeau A, Poynard T, Dubois S, Lesage G, Yvonnet B, Degott C, Bezeaud A, Rueff B, Benhamou J-P (1986) Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6: 648–651PubMedCrossRefGoogle Scholar
  3. 3.
    Beutler B, Carami A (1987) Cachectin: more than a tumor necrosis factor. N Engl J Med 316: 379–385PubMedCrossRefGoogle Scholar
  4. 4.
    Bissell DM, Choun MO (1988) The role of extracellular matrix in normal liver. Scand J Gastroenterol 23 (suppl 151): 1–7CrossRefGoogle Scholar
  5. 5.
    Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N (1988) Transforming growth factor Beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 85: 1539–1543PubMedCrossRefGoogle Scholar
  6. 6.
    Bucher NLR, Swaffield MN (1975) Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc Natl Acad Sci USA 72: 1157–1160PubMedCrossRefGoogle Scholar
  7. 7.
    Christensen E (1989) Prognostication in primary biliary cirrhosis: relevance to the individual patient. Hepatology 10: 111–113PubMedCrossRefGoogle Scholar
  8. 8.
    Christensen E, Bremmelgaard A, Bahnsen M, Andreasen PB, Tygstrup N (1984) Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol 19: 90–96PubMedGoogle Scholar
  9. 9.
    Cornell RP (1985) Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration. Am J Physiol 249: R551–R562PubMedGoogle Scholar
  10. 10.
    Decker K, Keppler D (1972) Galactosamine-induced liver injury. Prog Liver Dis 4: 183–199PubMedGoogle Scholar
  11. 11.
    Derynck R (1988) Transforming growth factor alpha. Cell 54: 593–595PubMedCrossRefGoogle Scholar
  12. 12.
    Desmet VJ, De Vos R (1984) Structural analysis of acute liver injury. In: Keppler D, Popper H, Bianchi L, Reutter W (eds) Mechanisms of hepatocyte injury and death. MTP Press, London, pp. 11–30Google Scholar
  13. 13.
    Diaz-Gil JJ, Sánchez G, Trilla C, Escartin P (1988) Identification of biliprotein as a liver growth factor. Hepatology 8: 484–486PubMedCrossRefGoogle Scholar
  14. 14.
    Didolkar MS, Fitzpatrick JL, Elias EG, Whitley N, Keramati B, Suter CM, Brown S (1989) Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 169: 17–26PubMedGoogle Scholar
  15. 15.
    Druker BJ, Mamón HJ, Roberts TM (1989) Onchogenesis, growth factors, and signal transduction. N Engl J Med 321: 1383–1391PubMedCrossRefGoogle Scholar
  16. 16.
    Ekberg S, Carlsson L, Carlsson B, Billig H, Jansson J-O (1989) Plasma growth hormone pattern regulates epidermal growth factor ( EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver. Endocrinology 125: 2158–2166PubMedCrossRefGoogle Scholar
  17. 17.
    Farrell G, Prendergast D, Murray M (1985) Halothane hepatitis. Detection of a constitutional susceptibility factor. N Engl J Med 313: 1310–1314PubMedCrossRefGoogle Scholar
  18. 18.
    Fehlmann M, Canivet B, Freychet P (1981) Epidermal growth factor stimulates monovalent cation transport in isolated rat hepatocytes. Biochem Biophys Res Commun 100: 254–260PubMedCrossRefGoogle Scholar
  19. 19.
    Francavilla A, Barone M, Todo S, Zeng Q, Porter KA, Starzl TE (1989) Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet ii: 1248–1249Google Scholar
  20. 20.
    Gerson RJ, Casini A, Gilfor D, Serroni A, Farber JL (1985) Oxygen-mediated cell injury in the killing of cultured hepatocytes by acetaminophen. Biochem Biophys Res Commun 126: 1129–1137PubMedCrossRefGoogle Scholar
  21. 21.
    Goldberg M (1985) Purification and partial characterization of a liver cell proliferation factor called hepatopoietin. J Cell Biochem 27: 291–302PubMedCrossRefGoogle Scholar
  22. 22.
    Hansen BA, Poulsen HE (1986) Changes in the hepatic capacity of urea-N synthesis, galactose elimination and antipyrine clearance following 70% hepatectomy in the rat. Scand J Clin Lab Invest 46: 233–237CrossRefGoogle Scholar
  23. 23.
    Jungermann K, Katz N (1989) Functional specialization of different hepatocyte populations. Physiol Rev 69: 708–764PubMedGoogle Scholar
  24. 24.
    Kan M, Huang J, Mansson P-E, Yasumitsu H, Carr B, McKeehan WL (1989) Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc Natl Acad Sci USA 86: 7432–7436PubMedCrossRefGoogle Scholar
  25. 25.
    Karavountzis GG, Redeker AG (1974) Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Ann Intern Med 80: 156–160Google Scholar
  26. 26.
    Krogsgaard K, Mathiesen LR, Aldershvile J, Kryger P, Andersson P, Hansson B-G, Nielsen JO, Ranek L, Copenhagen Hepatitis Acute Programme (1988) Delta infection and hepatitis B virus replication in Danish patients with fulminant hepatitis B. Scand J Infect Dis 20: 127–133PubMedCrossRefGoogle Scholar
  27. 27.
    La Brecque DR, Steele G, Fogerty S, Wilson M, Barton J (1987) Purification and physical-chemical characterization of hepatic stimulator substance. Hepatology 7: 100–106CrossRefGoogle Scholar
  28. 28.
    Leffert HL, Koch KS, Morgan T, Rubalcava B (1979) Hormonal control of rat liver regeneration. Gastroenterology 76: 1470–1482PubMedGoogle Scholar
  29. 29.
    Leffert HL, Koch KS, Shapiro P, Skelly H, Hubert J, Monken C, Lad PJ, Sala-Trepat J, Chisari FV (1987) Primary cultures, monoclonal antibodies and nucleic acid probes as tools for studies of hepatic structure and function. In: Tygstrup N, Orlandi F (eds) Cirrhosis of the liver: methods and fields of research. Elsevier, Amsterdam, pp 121–140Google Scholar
  30. 30.
    Leffert HL, Koch KS, Lad PJ, Shapiro IP, Skelly H, de Hemptinne B (1988) Hepatocyte regeneration, replication, and differentiation. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA (eds) The liver: biology and pathobiology. Raven, New York, pp. 833–849Google Scholar
  31. 31.
    Lipsky PE (1985) Role of interleukin-I in human B-cell activation. Contemp Top Mol Immunol 10: 195–217PubMedGoogle Scholar
  32. 32.
    Marti U, Burwen SJ, Jones AL (1989) Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology 9: 126–138PubMedCrossRefGoogle Scholar
  33. 33.
    Mead JE, Fausto N (1989a) Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 86: 1558–1562PubMedCrossRefGoogle Scholar
  34. 34.
    Mead JE, Fausto N (1989b) Regulation of liver growth: protooncogenes and transforming growth factors. Lab Invest 60: 4–13PubMedGoogle Scholar
  35. 35.
    Milandri M, Gaub J, Ranek L (1980) Evidence for liver cell proliferation during fatal acute liver failure. Gut 21: 423–427PubMedCrossRefGoogle Scholar
  36. 36.
    O’Grady JG, Alexander GJM, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97: 439–445PubMedGoogle Scholar
  37. 37.
    Okusawa S, Gelfand JA, Connolly RA, Dinarello CA (1987) Interleukin-I induces hemodynamic shock: reversal by a cyclooxygenase inhibitor. Fed Proc 46: 1200–1200Google Scholar
  38. 38.
    Perlmutter DH, Dinarello CA, Punsal P, Colten HR (1986) Cachectin/tumor necrosis factor regulates hepatic acute phase gene expression. J Clin Invest 78: 1349–1354PubMedCrossRefGoogle Scholar
  39. 39.
    Petersen KF, Hansen BA, Poulsen HE (1987) Hepatic regeneration following glucagon treatment. Horm Metab Res 19: 239–241 129Google Scholar
  40. 40.
    Poulsen HE, Korsholm B (1984) Quantitative liver functions after administration of allyl alcohol to rats. Acta Pharmacol Toxicol 54: 120–123CrossRefGoogle Scholar
  41. 41.
    Poulsen HE, Vilstrup H, Keiding S (1984) Galactose elimination kinetics in perfused rat liver after two thirds hepatectomy. Scand J Clin Lab Invest 44: 155–158PubMedCrossRefGoogle Scholar
  42. 42.
    Poulsen HE, Gaub J, Iversen J (1985) Changes in quantitative measures of hepatic function after 90% hepatectomy in rats. Eur J Clin Invest 15: 285–289PubMedCrossRefGoogle Scholar
  43. 43.
    Poulsen HE, Pilsgaard H (1985) Antipyrine metabolism during hepatic regeneration in the rat. Liver 5: 196–199PubMedGoogle Scholar
  44. 44.
    Ramse K, Buch Andreasen P, Ranek L (1980) Functioning liver mass in uncomplicated and fulminant acute hepatitis. Scand J Gastroenterol 15: 65–72CrossRefGoogle Scholar
  45. 45.
    Raper SE, Burwen SJ, Barker ME, Jones AL (1987) Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration. Gastroenterology 92: 1243–1250PubMedGoogle Scholar
  46. 46.
    Rappaport RS, Dodge GR (1982) Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 155: 943–948Google Scholar
  47. 47.
    Rozengurt E (1986) Early signals in the mitogenic response. Science 234: 161–166PubMedCrossRefGoogle Scholar
  48. 48.
    Russell WE, Coffey RJ, Ouellette AJ, Moses HL (1988) Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 85: 5126–5130PubMedCrossRefGoogle Scholar
  49. 49.
    Scotto J, Opolon P, Et J, Vergoz D, Thomas M, Caroli J (1973) Liver biopsy and prognosis in liver failure. Gut 14: 927–933PubMedCrossRefGoogle Scholar
  50. 50.
    Sinclair SB, Graig PD, Blendis LM, Abecassis M, Roberts EA, Phillips MJ, Cameron R, Levy GA (1989) Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. J Clin Invest 84: 1063–1069CrossRefGoogle Scholar
  51. 51.
    Skov Olsen P, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, Nexo E (1988) Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 8: 992–996PubMedCrossRefGoogle Scholar
  52. 52.
    Sporn MB, Roberts AB (1988) Peptide growth factors are multifunctional. Nature 332: 217–219PubMedCrossRefGoogle Scholar
  53. 53.
    Strain AJ (1988) Transforming growth factor beta and inhibition of hepatocellular proliferation. Scand J Gastroenterol 23, suppl. 151: 37–45CrossRefGoogle Scholar
  54. 54.
    Trey C, Lipworth L, Davidson CS (1970) Parameters influencing survival in the first 318 patients reported to the fulminant hepatic failure surveillance study. Gastroenterology 58: 306Google Scholar
  55. 55.
    Trump BF, Kim KM, Jones RT, Valigorsky JM (1976) Pathology of organelles in the human hepatic parenchymal cell. Prog Liver Dis 5: 51–68PubMedGoogle Scholar
  56. 56.
    Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, Miyazaki H, Sugihara J, Tomita E, Muto Y, Daikuhara Y, Hashimoto S (1989) Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 9: 875–881PubMedCrossRefGoogle Scholar
  57. 57.
    Tucker RF, Shipley GD, Moses HL (1984) Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science 226: 705–707PubMedCrossRefGoogle Scholar
  58. 58.
    Tygstrup N, Ranek L (1986) Assessment of prognosis in fulminant hepatic failure. Sem Liver Dis 6: 129–137CrossRefGoogle Scholar
  59. 59.
    Tygstrup N, Vallo-Hansen F, Tonnesen K, Keiding S (1974) Kinetics of galactose metabolism in the perfused pig liver. In: Lundquist F, Tygstrup N (eds) Regulation of hepatic metabolism. Munksgaard, Copenhagen, pp. 314–323Google Scholar
  60. 60.
    Tygstrup N, Gaub J, Ranek L (1981) Determination of liver function and liver regeneration in fulminant hepatic failure. In: Brunner G, Schmidt FW (eds) Artificial liver support. Springer Verlag, Berlin Heidelberg New York, pp. 39–45Google Scholar
  61. 61.
    Ulshen MH, Lyn-Cook LE, Raasch RH (1986) Effects of intraluminal epidermal growth factor on mucosal proliferation in the small intestine of adult rats. Gastroenterology 91: 1134–1140PubMedGoogle Scholar
  62. 62.
    Vilstrup H, Iversen J, Tygstrup N (1986) Glucoregulation in acute liver failure. Eur J Clin Invest 16: 193–197PubMedCrossRefGoogle Scholar
  63. 63.
    Vizzotto L, Romani F, Ferrario VF, Degna CT, Aseni P (1989) Characterization by morphometric model of liver regeneration in the rat. Am J Anat 185: 444–454PubMedCrossRefGoogle Scholar
  64. 64.
    Yildirim SI, Poulsen HE (1981) Quantitative liver functions after 70% hepatectomy. Eur J Clin Invest 11: 469–472PubMedCrossRefGoogle Scholar
  65. 65.
    Zapf J, Rinderknecht E, Humbel RE (1978) Non-suppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implication. Metabolism 27: 1803–1827PubMedCrossRefGoogle Scholar
  66. 66.
    Zieve FJ, Zieve L, Doizaki WM, Gilsdorf RB (1974) Synergism between ammonia and fatty acids in the production of coma: implications for hepatic coma. J Pharmacol Exp Ther 191: 10–16 131Google Scholar
  67. 67.
    Zimmerman HJ, Ishak KG (1982) Valporate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 2: 591–597PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • N. Tygstrup

There are no affiliations available

Personalised recommendations